Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Haralabos P Kalofonos Emmanouil V Dermitzakis Georgia XiromerisiouDimitrios RallisPanagiotis SoldatosPantelis LitsardopoulosMichail Vikelis

Published in: Journal of clinical medicine (2023)

A precise phenotypic profiling with identification of pain characteristics consistent with peripheral and/or central sensitization might reliably predict the responsiveness to fremanezumab in migraine prophylaxis.

Keyphrases

chronic pain
pain management
neuropathic pain
single cell
cross sectional
clinical trial
spinal cord injury